Abstract
Atrial fibrillation (AF) is a very common and relevant disease of the elderly (Fig. 1). Of the general population, 1%, but 10% of the 80+-year-old age group, suffer from it. In the United States alone, 2.2 million patients have AF, with an unknown number of undiagnosed cases (which may represent another two million patients), and this figure is expected to at least double by 2050. In Europe, the number of AF patients is estimated to be around six million.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alikhan R, Cohen AT, Combe S et al (2003) Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14:341–346
Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257–e354
Fuster V, Rydén LE, Cannom DS et al (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123:e269–e367
Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 suppl):381S–453S
Harenberg J, Bauersachs R, Diehm, C et al (2010) Antikoagulation im Alter [Anticoagulation in the elderly] Internist (Berl) 51:1446–1455, in German
Hohnloser SH, Crijns HJ, van Eickels M et al (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668–678
Nieuwlaat R, Capucci A, Lip GY, Euro Heart Survey Investigators et al (2006) Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation. Eur Heart J 27:3018–3026
Rossol-Haseroth K, Vogel CU, Reinecke F et al (2002) Empfehlungen zur Thromboembolieprophylaxe bei internistischen Patienten im Alter. Internist (Berl) 43:1134–1147
Roy D, Talajic M, Nattel S et al (2008) Atrial fibrillation and congestive heart failure investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677
Savelieva I, Camm AJ (2001) Clinical trends in atrial fibrillation at the turn of the millennium. J Intern Med 250:369–372
Spyropoulos AC, Merli G (2006) Management of venous thromboembolism in the elderly. Drugs Aging 23:651–671
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Study Acronyms
- AFASAK
-
Copenhagen Atrial Fibrillation, Aspirin, Anticoagulation Study
- AF-CHF
-
Atrial Fibrillation and Congestive Heart Failure
- AFFIRM
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management
- ARISTOTLE
-
Apixaban for the Prevention of Stroke in Subjects with Atrial Fibrillation
- ATHENA
-
A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400Â mg bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in Patients with Atrial Fibrillation/Atrial Flutter
- BAATAF
-
Boston Area Anticoagulation Trial for Atrial Fibrillation
- CAFA
-
Canadian Atrial Fibrillation Anticoagulation Study
- EAFT
-
European Atrial Fibrillation Trial
- MEDENOX
-
Prophylaxis in Medical Patients with Enoxaparin Study
- PALLAS
-
Permanent Atrial Fibrillation Outcome Study Using Dronedarone on Top of Standard Therapy
- RACE Studie
-
Rate Control Versus Electrical Cardioversion of Persistent Atrial Fibrillation Study
- RE-LY
-
Randomized Evaluation of Long Term Anticoagulant Therapy
- ROCKET AF
-
Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation
- SPAF Studie
-
Stroke Prevention in Atrial Fibrillation Study
- SPINAF Studie
-
Stroke Prevention in Nonrheumatic Atrial Fibrillation Study
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Wehling, M. (2013). Atrial Fibrillation. In: Wehling, M. (eds) Drug Therapy for the Elderly. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0912-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0912-0_9
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0911-3
Online ISBN: 978-3-7091-0912-0
eBook Packages: MedicineMedicine (R0)